QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs - PubMed (original) (raw)
QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs
Olarinde Jeffrey Ogunmola et al. Ann Afr Med. 2015 Oct-Dec.
Abstract
Background: QTc interval prolongation signifies an increased risk of life-threatening arrhythmia and sudden cardiac death. Cardiac manifestations of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome have become increasingly important causes of morbidity and mortality. We investigated HIV-positive patients to determine the effects of HIV infection, antiretroviral drugs, and identifiable confounders on QTc prolongation.
Materials and methods: A case-control study was conducted in a rural tertiary health center in Nigeria. Data collected included demographic variables, body mass index, blood pressure, HIV status, antiretroviral treatment (ART), duration of HIV infection and treatment, CD4 T-lymphocyte count, heart rate (HR), and QT interval. QT was corrected for HR using Bazett's formula.
Results: The sample frame comprised 89 (42.4%) HIV-negative subjects (39.3% male, 60.7% female; mean age, 36.28 ± 7.03 years); 45 (21.4%) HIV-positive, ART-naïve patients (31.1% male, 68.9% female; mean age, 36.48 ± 9.12 years); and 76 (36.2%) HIV-positive patients on ART (27.6% male, 72.4% female; mean age, 39.00 ± 7.68 years). The QTc interval and resting HR were higher in HIV-positive, drug-naïve patients than in the other two groups (P < 0.001). Female sex was associated with prolonged QTc intervals in all groups.
Conclusion: HIV-positive patients may be at higher risk of sudden cardiac death due to fatal arrhythmia secondary to QTc interval-related cardiac events. Healthcare providers should be aware that a prolonged QTc interval is a potential indicator of increased cardiovascular risk and should exercise caution in prescribing potentially QT-prolonging medications to HIV-positive patients.
Similar articles
- QTc interval prolongation in patients with HIV and AIDS.
Sani MU, Okeahialam BN. Sani MU, et al. J Natl Med Assoc. 2005 Dec;97(12):1657-61. J Natl Med Assoc. 2005. PMID: 16396057 Free PMC article. - QT dispersion in HIV-infected patients receiving combined antiretroviral therapy.
Wongcharoen W, Suaklin S, Tantisirivit N, Phrommintikul A, Chattipakorn N. Wongcharoen W, et al. Ann Noninvasive Electrocardiol. 2014 Nov;19(6):561-6. doi: 10.1111/anec.12162. Epub 2014 Apr 21. Ann Noninvasive Electrocardiol. 2014. PMID: 24750179 Free PMC article. - Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.
Vallecillo G, Mojal S, Roquer A, Martinez D, Rossi P, Fonseca F, Muga R, Torrens M. Vallecillo G, et al. Clin Infect Dis. 2013 Oct;57(8):1189-94. doi: 10.1093/cid/cit467. Epub 2013 Jul 29. Clin Infect Dis. 2013. PMID: 23899678 - QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
Trinkley KE, Page RL 2nd, Lien H, Yamanouye K, Tisdale JE. Trinkley KE, et al. Curr Med Res Opin. 2013 Dec;29(12):1719-26. doi: 10.1185/03007995.2013.840568. Epub 2013 Sep 23. Curr Med Res Opin. 2013. PMID: 24020938 Review. - Risk factors for QTc-prolongation: systematic review of the evidence.
Vandael E, Vandenberk B, Vandenberghe J, Willems R, Foulon V. Vandael E, et al. Int J Clin Pharm. 2017 Feb;39(1):16-25. doi: 10.1007/s11096-016-0414-2. Epub 2016 Dec 23. Int J Clin Pharm. 2017. PMID: 28012118 Review.
Cited by
- Does Engagement in HIV Care Affect Screening, Diagnosis, and Control of Noncommunicable Diseases in Sub-Saharan Africa? A Systematic Review and Meta-analysis.
Kileel EM, Zheng A, Bor J, Fox MP, Crowther NJ, George JA, Khoza S, Rosen S, Venter WDF, Raal F, Hibberd P, Brennan AT. Kileel EM, et al. AIDS Behav. 2024 Feb;28(2):591-608. doi: 10.1007/s10461-023-04248-0. Epub 2024 Feb 1. AIDS Behav. 2024. PMID: 38300475 Free PMC article. - Torsade de pointes associated with long-term antiretroviral drugs in a patient with HIV: a case report.
Mu X, Duan Y, Xu Q, Wang S, Gao G, Han N, Zhao H. Mu X, et al. Front Pharmacol. 2023 Oct 31;14:1268597. doi: 10.3389/fphar.2023.1268597. eCollection 2023. Front Pharmacol. 2023. PMID: 38027007 Free PMC article. - Longitudinal ECG changes among adults with HIV in Tanzania: A prospective cohort study.
Rahim FO, Sakita FM, Coaxum L, Maro AV, Ford JS, Hatter K, Gedion K, Ezad SM, Galson SW, Bloomfield GS, Limkakeng AT, Kessy MS, Mmbaga B, Hertz JT. Rahim FO, et al. PLOS Glob Public Health. 2023 Oct 25;3(10):e0002525. doi: 10.1371/journal.pgph.0002525. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37878582 Free PMC article. - Prevalence and Correlates of Ischemic ECG Findings among Adults With and Without HIV in Tanzania.
Prattipati S, Sakita FM, Tarimo TG, Kweka GL, Mlangi JJ, Maro AV, Coaxum LA, Galson SW, Limkakeng AT, Rugakingira A, Urasa SJ, Okeke NL, Mmbaga BT, Bloomfield GS, Hertz JT. Prattipati S, et al. Glob Heart. 2022 Jun 10;17(1):38. doi: 10.5334/gh.1127. eCollection 2022. Glob Heart. 2022. PMID: 35837355 Free PMC article. - Linear and non-linear analysis of heart rate variability in HIV-positive patients on two different antiretroviral therapy regimens.
Gonçalves AJ, Braga MVA, Santana PH, Resende LAPR, da Silva VJD, Correia D. Gonçalves AJ, et al. BMC Infect Dis. 2021 Sep 29;21(1):1022. doi: 10.1186/s12879-021-06648-w. BMC Infect Dis. 2021. PMID: 34587909 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials